骨梗死模拟骨转移:18F-PSMA PET/CT一例
本文报道一例70岁前列腺腺癌根治术后生化复发患者,在18F-PSMA PET/CT中发现左股骨新发局灶性中度PSMA摄取,5个月前PSMA显像正常,随后MRI证实该摄取对应新发股骨骨梗死。文献检索未发现既往报道PSMA示踪剂在骨梗死中摄取的病例。
要点
- 18F-PSMA PET/CT中骨梗死可表现为局灶性摄取,模拟骨转移。
- 新发局灶性PSMA摄取需结合MRI等影像鉴别骨梗死与转移。
- 前列腺癌生化复发评估中,PSMA摄取灶并非均为肿瘤。
核心结论
- 骨梗死可导致18F-PSMA局灶性摄取,模仿骨转移,文献中未见既往报道。
研究设计与样本
- 个案报道:70岁前列腺腺癌根治术后生化复发男性,行18F-PSMA PET/CT检查。
主要发现
- 左股骨出现新发局灶性中度PSMA摄取,5个月前PSMA检查正常。
- 后续MRI显示PSMA摄取对应新发股骨骨梗死。
- 英文文献检索未发现PSMA示踪剂在骨梗死中摄取的既往病例。
临床怎么用
- 前列腺癌患者PSMA PET/CT新发局灶骨摄取时,应鉴别骨梗死可能,必要时行MRI确认。
局限性
- 为单例个案报道,证据级别有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
18F-prostate-specific membrane antigen (PSMA) PET/CT imaging is increasingly used in staging, assessment of biochemical recurrence, and treatment response in men with prostate cancer. We present a case report of a 70-year-old man who underwent 18F-PSMA PET/CT imaging to investigate biochemical recurrence following radical prostatectomy for prostate adenocarcinoma. New focal moderate PSMA uptake was identified in the left femur. A previous PSMA study, performed 5 months earlier, was normal. A subsequent MRI scan demonstrated that the PSMA avidity corresponded to a new femoral bone infarct. An English literature search revealed no previous cases of PSMA tracer uptake in bone infarction.
引用
- Elsobky S, Nathan M, Robertson N, et al. Bone Infarction Mimicking a Bone Metastasis on 18F-Prostate-Specific Membrane Antigen PET/CT. Clin Nucl Med. 2021. PMID: 33323731. doi:10.1097/RLU.0000000000003455
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。